Sander van Duijnhoven

Sander van Duijnhoven has an extensive work experience in various scientific roles across multiple companies. Sander started their career as a Student at Eindhoven University of Technology in 2002. Later, they worked as a Research Scientist at Philips. Their experience led him to roles in different companies such as Tagworks Pharmaceuticals, Radboudumc, BioNovion, and Aduro Biotech Europe. Currently, they serve as the Scientific Director at IPA (ImmunoPrecise Antibodies), where they previously held positions as Program Scientist and Project Team Leader. Their background includes significant contributions to the development of molecular imaging probes.

Sander van Duijnhoven obtained their MSc in Biomedical Engineering from Eindhoven University of Technology in 2008, followed by a Doctor of Philosophy (Ph.D.) in Biomedical Engineering from the same institution in 2012. Additionally, they hold certifications in Technisch Management, Fundamentals of Biostatistics, Laboratory Animal Science, Radiation Protection Level 5B, and Safe Microbiological Techniques.